Asset Details
Do you wish to reserve the book?
Dose Sparing with Intradermal Injection of Influenza Vaccine
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Dose Sparing with Intradermal Injection of Influenza Vaccine
Do you wish to request the book?
Dose Sparing with Intradermal Injection of Influenza Vaccine
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Dose Sparing with Intradermal Injection of Influenza Vaccine
2004
Overview
In this trial, 50 healthy adults 18 to 40 years of age received an intradermal injection of one fifth the standard dose of an influenza vaccine. The resulting increases in hemagglutination-inhibition titers were at least similar to those elicited by the standard dose of vaccine administered intramuscularly to 50 control subjects.
50 healthy adults received an intradermal injection of one fifth the standard dose of an influenza vaccine. The use of reduced doses of vaccine may be one way of expanding a limited supply of vaccine.
Vaccination against influenzavirus is an important public health measure to help protect against the annual morbidity and mortality associated with influenza. A major global supplier of influenza vaccine recently experienced manufacturing problems that led regulatory authorities to declare more than 48 million doses, almost half the U.S. supply of influenza vaccine, unfit for use.
1
This has created a public health crisis, with widespread shortages leaving many in the United States without vaccine coverage. Various emergency measures are being considered in an effort to expand the supply and consist either of reducing the intramuscular dose or importing doses from manufacturers that . . .
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Biological and medical sciences
/ Female
/ Hemagglutinin Glycoproteins, Influenza Virus - immunology
/ Humans
/ Influenza A virus - immunology
/ Influenza B virus - immunology
/ Influenza Vaccines - administration & dosage
/ Influenza Vaccines - adverse effects
/ Influenza Vaccines - immunology
/ Influenza, Human - immunology
/ Influenza, Human - prevention & control
/ Male
/ Skin
/ Vaccines
